Headlines about National Research (NASDAQ:NRCIA) have trended somewhat positive on Saturday, Accern Sentiment reports. The research group scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. National Research earned a media sentiment score of 0.07 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.7256182643686 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Shares of National Research (NASDAQ NRCIA) opened at $30.65 on Friday. National Research has a 12 month low of $16.90 and a 12 month high of $41.99. The stock has a market cap of $718.22, a PE ratio of 58.94 and a beta of 1.75.

The company also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Stockholders of record on Friday, March 30th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 1.31%. The ex-dividend date of this dividend is Wednesday, March 28th. National Research’s payout ratio is currently 76.92%.

Several equities research analysts have recently issued reports on the stock. Zacks Investment Research raised shares of National Research from a “strong sell” rating to a “hold” rating in a research note on Wednesday, January 10th. BidaskClub raised shares of National Research from a “hold” rating to a “buy” rating in a research note on Wednesday, December 27th.

In related news, major shareholder Amandla Mk Trust purchased 5,494,440 shares of the firm’s stock in a transaction that occurred on Thursday, February 15th. The shares were purchased at an average cost of $19.31 per share, with a total value of $106,097,636.40. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Michael D. Hays sold 1,602,399 shares of the firm’s stock in a transaction dated Thursday, January 25th. The shares were sold at an average price of $39.03, for a total transaction of $62,541,632.97. Following the completion of the transaction, the chief executive officer now directly owns 5,261,410 shares in the company, valued at $205,352,832.30. The disclosure for this sale can be found here. Corporate insiders own 37.54% of the company’s stock.

TRADEMARK VIOLATION WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.dailypolitical.com/2018/03/03/national-research-nrcia-receiving-somewhat-favorable-media-coverage-report-finds.html.

About National Research

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Insider Buying and Selling by Quarter for National Research (NASDAQ:NRCIA)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.